Table 1.
Design | Patient Characteristics | Reference Standard | MRI-PDFF cut-off | Accuracy/Correlation | |
---|---|---|---|---|---|
Permutt et al.29 | Cross-sectional, prospective cohort |
51 adult; biopsy proven NAFLD; AST/ALT above ULN; no alternative etiology |
Liver biopsy NASH- CRN histology; single blinded liver pathologist |
Grade 1: 8.9% Grade 2: 16.3% Grade 3: 25% |
r2 =0.56; patients with stage 4 fibrosis had lower quantified steatosis |
Tang et al.53 | Cross-sectional, prospective cohort |
77 adult and pediatric; biopsy proven NAFLD; no alternative etiology |
Liver biopsy NASH- CRN histology; blinded liver pathologist |
Grade 1: 6.4% Grade 2: 17.4% Grade 3: 22.1% |
AUC 0.989 grade 1; AUC 0.825 ≥ grade 2; AUC 0.893 ≥ grade 3 |
Idilman et al.56 | Retrospective, cohort |
70 adult; biopsy proven NAFLD; no alternative etiology |
Liver biopsy NASH- CRN histology; blinded liver pathologist |
Grade 2/3: 15% | AUC 0.950 ≥ grade 2; correlation decreased when fibrosis present |
Bannas et al.57 | Cross-sectional, prospective cohort |
13 liver donors where livers were deemed unsuitable for transplant |
Five core biopsies from 9 segments (45 cores per liver); NASH-CRN histology; 2 blinded liver pathologists |
n/a | Strong correlation with histology (r2=0.850), smaller variance for MRI-PDFF than for histologic steatosis |
Heba ER et al.58 | Retrospective, cohort |
506 adult; biopsy proven or suspected NAFLD; no alternative etiology |
Right lobe magnetic resonance spectroscopy |
n/a | 2-D echo least accurate, 3-D echo most accurate, results influenced by BMI and gender (males) |
NAFLD: non-alcoholic fatty liver disease; NASH: non-alcoholic steatohepatitis; AUC: area under the curve; r2 = correlation coefficient